Marpai Q1 2025 revenue $5.4M down 27% YoY; operating loss narrows 45% to $2.3M

Marpai, Inc.

2025-Q1 EPS reported -$0.21 revenue$5,418,000

Net revenue $5.4M, down $2.0M (27%) vs Q1 2024; operating expenses cut 33% to $7.7M.
Operating loss improved 45% to $2.3M; net loss $3.1M improved 29% vs prior year.
EPS of ($0.21), improvement of $0.25 per share year over year.
Unrestricted cash $0.7M at quarter end; CEO targets profitability and positive cash flow by end of 2025.
Key initiatives: launch of Healthcare Management tool with Empara, MarpaiRx advancements, new COO Dallas Scrip onboarded.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.